Jord BioScience, a U.S.-based pioneer in microbial solutions for agriculture, has raised $7 million in its Series B funding round to accelerate the development and commercialization of its next-generation biological crop inputs. This investment underscores the growing confidence in microbial technologies as the future of sustainable farming.

Founded on over 30 years of research from the University of Minnesota, Jord BioScience specializes in enhancing the performance of microbial products used in agriculture. Under the leadership of Dr. Linda Kinkel, Chief Science Officer, the company has amassed a microbial bank of over 6,500 isolates sourced from diverse global soils. These isolates are optimized to improve crop performance by enhancing plant-microbe interactions, a crucial step in addressing the long-term impacts of extensive pesticide and fertilizer use.

Jord BioScience collaborates with agribusinesses to fast-track biological product innovation. Its tailored microbial formulations are designed to extend product lifecycles, improve consistency, and broaden the adoption of biologicals in mainstream agriculture. Currently, the company is conducting extensive field trials across the U.S., Argentina, and Brazil, testing solutions for staple crops such as corn, soybeans, canola, wheat, and various specialty crops.

The Series B funding round was led by Silver Blue LLC, a Maryland-based agrifood technology investor, with additional backing from Discovery Capital Funding and Minnesota’s Small Business Credit Initiative Direct Investment. This capital infusion will support Jord BioScience in scaling its R&D, expanding market reach, and strengthening partnerships with industry leaders.

“This funding round marks a major milestone for Jord BioScience, validating our partnership approach and the transformative potential of our microbial solutions in modern agriculture.”

— Dr. Keri Carstens, President and CEO of Jord BioScience

The agricultural microbial sector is rife with challenges, including inconsistent field performance, short shelf-life, compatibility issues, and regulatory complexities. Jord BioScience is tackling these obstacles by focusing on the interactions between microbes, ensuring their optimal function when applied to crops. This approach not only enhances yield and efficiency but also improves the scalability and reliability of biological solutions for farmers.

By leveraging its deep expertise in microbial science, Jord BioScience aims to bridge the gap between research and commercial viability, making microbial solutions more effective and widely accessible.

As the agriculture industry moves toward sustainable practices, Jord BioScience’s microbial innovations align with the global shift to reduce synthetic inputs and improve soil health. The company’s advancements in microbial customization signal a promising future for bio-based agricultural solutions, positioning it as a key player in the biologicals market.

With this latest investment, Jord BioScience is poised to scale its impact, helping farmers worldwide harness the power of microbes to drive sustainable, high-performance agriculture.